• On 10 February 2026, Americas Gold and Silver Corporation announced a definitive joint venture agreement with United States Antimony to build and operate a new antimony processing plant in Idaho’s Silver Valley, with Americas holding 51% and US Antimony 49% ownership.
• This partnership links Americas’ mine feed from the Galena Complex with US Antimony’s processing and marketing capabilities, creating a fully U.S.-based mine-to-finished antimony supply chain that could align with federal critical mineral priorities and potential funding.
• Next, we’ll examine how this Idaho processing joint venture and its fully domestic antimony supply chain could reshape United States Antimony’s investment narrative.

Find 56 companies with promising cash flow potential yet trading below their fair value.

United States Antimony Investment Narrative Recap

To own United States Antimony, you have to believe in its role as a core U.S. critical minerals processor and its ability to translate capacity growth into sustainable, profitable volumes. The Idaho joint venture fits neatly into that story by adding a fully domestic mine to finished product pathway, but the key near term catalyst remains proving that new processing and offtake agreements can move the company closer to profitability, while the biggest risk is still execution and funding across multiple expansion projects.

Among recent announcements, the five year antimony trioxide supply agreement worth up to US$106.7 million stands out alongside the Idaho JV. Together, contracted demand and new processing capacity could support higher utilization if US Antimony can secure sufficient feedstock and keep costs under control, partially addressing concerns about underused assets and earnings volatility while also testing how resilient margins are when antimony pricing or contract terms become less favorable.

Yet even with the Idaho JV, investors should still be aware of how dependent the thesis is on large, concentrated contracts and what happens if any of them...

United States Antimony's narrative projects $208.1 million revenue and $82.5 million earnings by 2028. This requires 100.7% yearly revenue growth and an $83.4 million earnings increase from -$0.9 million.

Uncover how United States Antimony's forecasts yield a $9.67 fair value, a 33% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already modeling revenue of about US$333 million and earnings near US$72 million by 2029, so this Idaho JV and the greater reliance on large, long term contracts could either reinforce that bullish view or highlight how sensitive those forecasts are to pricing cycles and customer concentration, reminding you that reasonable people can read the same story very differently.

Explore 20 other fair value estimates on United States Antimony - why the stock might be worth over 5x more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your United States Antimony research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free United States Antimony research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate United States Antimony's overall financial health at a glance.

Searching For A Fresh Perspective?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Capitalize on the AI infrastructure supercycle with our selection of the 34 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 24 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.